Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q4 2020 Earnings

5NovConfirmed

Q1 2020

Q2 2020

Q3 2020

Q4 2020

-12.04

-10.8

-9.56

-8.32

Details

Expected EPS

-9.28032

Actual EPS

-12.04232

Surprise EPS

-2.76

Surprise Percent

+29.76%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -12.04232 per share for Q4 2020.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.